Comparison of newly developed immuno-MS method with existing DELFIA®immunoassay for human chorionic gonadotropin determination in doping analysis

Bioanalysis ◽  
2013 ◽  
Vol 5 (5) ◽  
pp. 623-630 ◽  
Author(s):  
Hanne Lund ◽  
Ann Helene Snilsberg ◽  
Trine Grønhaug Halvorsen ◽  
Peter Hemmersbach ◽  
Léon Reubsaet

2012 ◽  
Vol 84 (18) ◽  
pp. 7926-7932 ◽  
Author(s):  
Hanne Lund ◽  
Karoline Løvsletten ◽  
Elisabeth Paus ◽  
Trine Grønhaug Halvorsen ◽  
Léon Reubsaet




2016 ◽  
Vol 8 (11-12) ◽  
pp. 1147-1151 ◽  
Author(s):  
Anthony W. Butch ◽  
Getachew A. Woldemariam


2010 ◽  
Vol 31 (10) ◽  
pp. 2889-2892 ◽  
Author(s):  
Min-Jung Kang ◽  
Hye-Im Lee ◽  
Sang-Mi Shin ◽  
Hye-Hyun Yoo ◽  
Oh-Seung Kwon ◽  
...  


1998 ◽  
Vol 37 (08) ◽  
pp. 297-298 ◽  
Author(s):  
A. Özet ◽  
A. Arpaci ◽  
S. Kömiircü ◽  
G. Üçkaya

Summary50 years old man suffering from primary lung adenocarcinoma presented with high levels of both beta subunit human chorionic gonadotropin (βHCG) and cancer antigen 15-3 (CA 15-3) in the absence of elevated carcinoembrionic antigen (CEA), alfa fetoprotein (AFP) and carbohydrate antigen 19-9 (CA 19-9). Although βHCG or CA 15-3 high levels were reported in adenocarcinoma of lung, this is the first report of a patient with high levels of both markers.



1973 ◽  
Vol 71 (4_Suppl) ◽  
pp. S54 ◽  
Author(s):  
U. Hilgenfeldt ◽  
W. E. Merz ◽  
R. Brossmer


Sign in / Sign up

Export Citation Format

Share Document